2016 annual financial data
Inhibikase Therapeutics 2016 Financial results
Direct answer
Revenue was 967,386 USD.
Operating income was -613,288 USD and net income was -628,737 USD.
Operating cash flow was -29,573 USD.
Get free Inhibikase Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 967,386 USD
- Operating income
- -613,288 USD
- Net income
- -628,737 USD
- Operating cash flow
- -29,573 USD
Explore related company data
View all 2016 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all Inhibikase Therapeutics financial years